Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T.R.U.E. TEST Panel 3.2 in Pediatric Contact Dermatitis
NCT01518348Phase 3Withdrawn
- Sponsor
- Allerderm Laboratories, Inc.
- Start
- Dec 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethylenediamine dihydrochloride in allergic contact dermatitis (ACD), sponsored by Allerderm Laboratories, Inc.. Planned start Dec 2012; status: withdrawn.
02
Drugs
ethylenediamine dihydrochloride
03
Conditions
allergic contact dermatitis (ACD)
Beyond the preview
Go deeper on NCT01518348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01518348.